Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
9,966.00
8,991.00
12,793.00
8,569.00
7,192.00
9,223.00
8,512.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,966.00
8,991.00
12,793.00
8,569.00
7,192.00
9,223.00
8,512.00
Raw Material Cost
3,429.00
2,430.00
1,955.00
2,395.00
3,943.00
2,722.00
2,141.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
90.00
151.00
78.00
79.00
52.00
40.00
37.00
Selling and Distribution Expenses
3,082.00
2,962.00
3,354.00
3,470.00
3,256.00
3,212.00
3,297.00
Other Expenses
329.90
538.60
440.90
326.90
545.40
330.90
336.40
Total Expenditure (Excl Depreciation)
9,900.00
10,929.00
9,796.00
9,213.00
12,705.00
9,283.00
8,839.00
Operating Profit (PBDIT) excl Other Income
66
-1938
2997
-644
-5513
-60
-327
Other Income
427.00
490.00
420.00
-27.00
-103.00
339.00
-998.00
Operating Profit (PBDIT)
1,032.00
-889.00
4,138.00
67.00
-4,748.00
1,118.00
-484.00
Interest
90.00
151.00
78.00
79.00
52.00
40.00
37.00
Exceptional Items
0.00
1,882.00
0.00
0.00
0.00
0.00
437.00
Gross Profit (PBDT)
6,537.00
6,561.00
10,838.00
6,174.00
3,249.00
6,501.00
6,371.00
Depreciation
539.00
559.00
721.00
738.00
868.00
839.00
841.00
Profit Before Tax
402.00
281.00
3,342.00
-751.00
-5,666.00
239.00
-925.00
Tax
27.00
157.00
1,029.00
-180.00
-1,747.00
37.00
-40.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
400.00
69.00
2,291.00
-546.00
-3,884.00
115.00
-891.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
400.00
69.00
2,291.00
-546.00
-3,884.00
115.00
-891.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-24.00
55.00
21.00
-24.00
-34.00
87.00
7.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
376.00
124.00
2,312.00
-570.00
-3,918.00
202.00
-884.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
46,942.00
46,659.00
48,491.00
46,264.00
47,342.00
52,576.00
56,704.00
Earnings per share (EPS)
3.27
0.56
18.8
-4.48
-31.88
0.94
-7.14
Diluted Earnings per share
3.27
0.56
18.8
-4.48
-31.88
0.94
-7.14
Operating Profit Margin (Excl OI)
0.66%
-21.55%
23.43%
-7.52%
-76.65%
-0.65%
-3.84%
Gross Profit Margin
9.44%
9.34%
31.76%
-0.15%
-66.71%
11.69%
-0.99%
PAT Margin
4.01%
0.77%
17.91%
-6.37%
-54.0%
1.25%
-10.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 10.84% vs -29.72% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 203.23% vs -94.64% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 143.87% vs -137.09% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -40.40% vs 93.59% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of JCR Pharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(JPY)
Change(%)
Net Sales
9,966.00
46,812.00
-36,846.00
-78.71%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,966.00
46,812.00
-36,846.00
-78.71%
Raw Material Cost
3,429.00
34,858.00
-31,429.00
-90.16%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
90.00
529.00
-439.00
-82.99%
Selling and Distribution Expenses
3,082.00
8,118.00
-5,036.00
-62.03%
Other Expenses
329.90
306.40
23.50
7.67%
Total Expenditure (Excl Depreciation)
9,900.00
46,569.00
-36,669.00
-78.74%
Operating Profit (PBDIT) excl Other Income
66.00
243.00
-177.00
-72.84%
Other Income
427.00
-243.00
670.00
275.72%
Operating Profit (PBDIT)
1,032.00
0.00
1,032.00
Interest
90.00
529.00
-439.00
-82.99%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
6,537.00
11,954.00
-5,417.00
-45.32%
Depreciation
539.00
0.00
539.00
Profit Before Tax
402.00
-529.00
931.00
175.99%
Tax
27.00
-1,183.00
1,210.00
102.28%
Provisions and contingencies
0
0
0.00
Profit After Tax
400.00
654.00
-254.00
-38.84%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
400.00
654.00
-254.00
-38.84%
Share in Profit of Associates
0
0
0.00
Minority Interest
-24.00
0.00
-24.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
376.00
654.00
-278.00
-42.51%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
46,942.00
1,78,556.00
-1,31,614.00
-73.71%
Earnings per share (EPS)
3.27
-2.69
5.96
221.56%
Diluted Earnings per share
3.27
-2.69
5.96
221.56%
Operating Profit Margin (Excl OI)
0.66%
0.52%
0.00
0.14%
Gross Profit Margin
9.44%
-1.13%
0.00
10.57%
PAT Margin
4.01%
1.40%
0.00
2.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 996.60 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 10.84% vs -29.72% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 38.57% vs -21.42% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 37.60 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 203.23% vs -94.64% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 109.60% vs -1,176.37% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 60.50 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 143.87% vs -137.09% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 113.02% vs -815.72% in Mar 2025
Quarterly - Interest
Interest 9.00 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -40.40% vs 93.59% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 73.08% vs 126.09% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.66%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
